Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Abstract Oncotype DX® (ODX) guides adjuvant chemotherapy decisions in early breast cancer (eBC), but its high-cost limits access in resource-constrained settings. We developed and evaluated an interpretable machine learning model using routinely available clinicopathologic variables to predict ODX recurrence score (RS) and optimize genomic testing. We analyzed 935 Brazilian patients with eBC from the GBECAM cohort (2005–2024).
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.